Healthcare
MatsukiyoCocokara & Co.(MSMKF)
Live Price
Offline$13.50
+0.00% today
1Y Change
-19.36%
Window
Jun 25, 2025 → Jun 24, 2026
- Market Cap
- $922.59B
- Revenue Growth
- +3.8%
- EPS Growth
- +6.8%
- Dividend Yield
- 2.1%
Coverage: 256 bars · Jun 25, 2025 → Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
MatsukiyoCocokara & Co. (MSMKF) is a Healthcare stock with a market cap of $922.59B and listed on OTC. The stock last traded around $13.50 and down 19.4% across the available one-year price window (Jun 25, 2025 → Jun 24, 2026). Baseline metrics include revenue growth of +3.8%, EPS growth of +6.8%, a dividend yield of 2.1%. What stands out right now is revenue +3.8%, EPS +6.8%, free cash flow +54.4% with operating margin 7.7% and ROIC 9.8%. The dividend is present but secondary, with a yield around 2.1%. Valuation is more restrained than many high-expectation growth names at P/E 16.5 and price/sales 0.8. Stock Foundry combines MSMKF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+3.8% vs +7.6% peer median
Operating Margin
Below sector median
+7.7% vs +19.4% peer median
P/E
Below sector median
16.5 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating story is still moving forward
Revenue is running at +3.8% and EPS at +6.8%, with operating margin around 7.7%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 2.1%, which matters if the thesis depends on income as much as growth.
Benchmark Edge
MSMKF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
MSMKF
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
MSMKF Max Drawdown
-36.31%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for MSMKF and SPY.
Company Overview
MatsukiyoCocokara & Co.
Other OTC
MatsukiyoCocokara & Co. operates a chain of drug stores and pharmacies in Japan. As of June 30, 2020, it operated through a network of 1,726 stores in 47 prefectures in Japan. MatsukiyoCocokara & Co. was founded in 1932 and is based in Matsudo, Japan.
- Leadership
- Kiyoo Matsumoto
- IPO Date
- Jun 27, 2014
- Employees
- 13.4k
- Street Address
- 9-1 Shinmatsudo-Higashi
- Mailing
- Matsudo, 270-8511
- Region
- Matsudo, JP
- Reporting Currency
- USD
- Investor Line
- 81 47 344 5110
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 16.5
- EV/EBITDA
- 7.8
- Price/Sales
- 0.8
- Price/Book
- 1.7
Growth
- Revenue
- +3.8%
- EPS
- +6.8%
- Free Cash Flow
- +54.4%
Profitability
- Gross Margin
- 34.6%
- Operating Margin
- 7.7%
- Net Margin
- 5.1%
- ROE
- 10.8%
- ROIC
- 9.8%
Balance Sheet
- Debt/Equity
- 0.03
- Current Ratio
- 2.18
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.